Results 211 to 220 of about 8,387 (243)
Some of the next articles are maybe not open access.
Antioxidant Properties of an Antiischaemic Agent : Trimetazidine
1990Trimetazidine (TMZ) has now been widely used throughout the world for more than ten years for the treatment of cellular manifestation of ischaemic disorders including coronary heart diseases, retinopathies and cochleo-vestibular diseases. Its efficacy has been assessed in double-blind studies versus placebo and versus reference drugs.
P, Clauser, C, Harpey
openaire +2 more sources
Regulatory effects of trimetazidine in cardiac ischemia/reperfusion injury
Naunyn-Schmiedeberg's Archives of Pharmacology, 2023M. Farzaei +7 more
semanticscholar +1 more source
Trimetazidine in Cardiovascular Disease and Beyond: A Comprehensive Review
American Journal of Cardiovascular DrugsHarsh Goel +6 more
semanticscholar +1 more source
Trimetazidine affects pyroptosis by targeting GSDMD in myocardial ischemia/reperfusion injury
Inflammation Research, 2022Xu-Dong Chen +8 more
semanticscholar +1 more source